Clinical Trials Browser

Phase 2 × Virus Diseases × Rituximab × Clear all

NCT01136395 2019-10-08

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Phase 2 Completed

Virus Diseases, Epstein-Barr Virus Infections